| Vol. 10.42 – 18 November, 2021 |
| |
|
|
| Researchers performed large-scale targeted metabolomics on resected lesions and plasma obtained from invasive lung adenocarcinoma and its precursors, and deciphered the metabolic trajectories from atypical adenomatous hyperplasia to adenocarcinoma in situ. [Nature Communications] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors demonstrated that lipopolysaccharide promoted c-Jun N-terminal kinase signaling pathway activation and endogenous tumor necrosis factor-α secretion in pulmonary macrophages. [Laboratory Investigation] |
|
|
|
| Scientists evaluated the toxicity of stainless and mild steel particles generated via gas–metal arc welding using primary human small airway epithelial cells and ToxTracker reporter murine stem cells, which tracked activation of six cancer-related pathways. [Scientific Reports] |
|
|
|
| Researchers found that ouabain, digitoxin, and digoxin blocked penetration by SARS-CoV-2 spike-pseudotyped virus into human lung cells, and infectivity by native SARS-CoV-2. [Scientific Reports] |
| |
|
|
| Investigators performed single-cell RNA sequencing of 268,471 cells collected from 25 patients in four histologic stages of lung adenocarcinoma and compared them to normal cell types. [Nature Communications] |
|
|
|
| Researchers showed that the expression of TIAM1, an activator of the small GTPase RAC1, was associated with a neuroendocrine gene program. [Cell Reports] |
|
|
|
| Scientists explored the mechanisms regulating histone methylation in lung adenocarcinoma (LUAD) in response to smoking. They found that the histone H3K9 methylation reader CBX3 was upregulated in current smokers with LUAD, and that CBX3 overexpression promoted LUAD progression. [Oncogene] |
|
|
|
| The authors showed that ubiquitin specific peptidase 5 (USP5) directly interacted with PD-L1 and deubiquitinated PD-L1, therefore enhances PD-L1 protein stability. [Cell Death & Disease] |
|
|
|
| Scientists performed the first drug repurposing screen to identify compounds that conferred synthetic lethality with LIM domains containing 1 (LIMD1) loss in NSCLC cells. [Cell Death & Disease] |
| |
|
|
|
| The authors consider elastin’s involvement in chronic respiratory disease and examine recent methods for imaging and modeling of the lung in the context of advances in lung tissue engineering for research and clinical application. [Current Opinion in Biotechnology] |
|
|
|
|
| An interdisciplinary team of Northwestern Medicine investigators led by Karen Ridge, PhD, has been awarded a $14 million grant from the National Institute of Health’s National Heart, Lung, and Blood Institute to investigate the mechanisms that promote lung tissue repair in patients with severe viral pneumonia. [Northwestern Medicine] |
|
|
|
| GlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the COMET-TAIL Phase III trial, which achieved its primary endpoint, demonstrating intramuscular administration of sotrovimab was non-inferior to intravenous administration for the early treatment of mild-to-moderate COVID-19 in high-risk, non-hospitalised adults and adolescents. [GlaxoSmithKline plc] |
|
|
|
|
| December 5 – 9, 2021 Jupiter, Florida, United States |
|
|
|
|
|
| NUI Galway – Galway, Ireland |
|
|
|
| Medical College of Wisconsin – Milwaukee, Wisconsin, United States |
|
|
|
| University of Pennsylvania – Philadelphia, Pennsylvania, United States |
|
|
|
| MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| University of Pittsburgh – Pittsburgh, Pennsylvania, United States |
|
|
|
|